Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients

BACKGROUND: In patients with atrial fibrillation (AF) treated with direct oral anticoagulants (DOAC), bleeding risk scores provide only modest discrimination for major or intracranial bleeding. However, warfarin experience may impact HAS‐BLED  (Hypertension, Abnormal renal/liver function, Stroke, Bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Perino, Alexander C., Fan, Jun, Pundi, Krishna, Schmitt, Susan, Kothari, Mitra, Din, Natasha, Heidenreich, Paul A., Turakhia, Mintu P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451662/
https://www.ncbi.nlm.nih.gov/pubmed/35946047
http://dx.doi.org/10.1002/clc.23887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451662/
https://www.ncbi.nlm.nih.gov/pubmed/35946047
http://dx.doi.org/10.1002/clc.23887

Ejemplares similares